News Archive

March 2020

• Press Release Mar 17, 2020

  Novartis announces broad range of initiatives to respond to COVID-19 Pandemic; Creates USD 20 million global fund to support impacted communities

  Novartis COVID-19 Response Fund will provide grants of up to USD 1 million to support communities around the world most impacted by the Coronavirus outbreak  Novartis to join collaborative R…
• Featured News Mar 13, 2020

  Novartis coronavirus update (remote working, business travel restrictions)

• Featured News Mar 11, 2020

  Novartis provides update on use and safety of Beovu® in patients with wet AMD

• 
  Story Mar 11, 2020 Discovery

  The data42 program shows Novartis’ intent to go big on data and digital

  Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.

• 
  Story Mar 11, 2020 Discovery

  Meet Achim, leading the data42 program

  The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.

• Statement Mar 11, 2020

  Novartis coronavirus update (supply chain, response measures, EFPIA R&D call)

• 
  Story Mar 09, 2020 People and Culture

  Novartis Social Business Careers: improving health in lower income countries

  This is the story of how three Novartis colleagues took a career decision to improve health in lower income countries.

• Featured News Mar 06, 2020

  International Women’s Day 2020

  To celebrate International Women’s Day we explore how an inclusive environment that values unique and curious minds helps everyone be inspired to innovate every day.

• 
  Story Mar 05, 2020 From Our Labs

  Advancing medicine through collaboration

  In Wendi Yajnik’s quest to find new technologies that could transform medicine, relationships are priority No. 1.

• 
  Story Mar 04, 2020 Discovery

  Clinical trial comes together in weeks to address coronavirus

  Researchers race to put hydroxychloroquine to the test in a large study.

• Press Release Mar 03, 2020

  International research partnership and EDCTP to invest €44m in next-generation antimalarials to combat drug-resistant malaria in Africa

  EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings…
• Key Release Mar 02, 2020

  Sandoz Resolves Generic Drug Antitrust Investigation in the U.S.

  Princeton, New Jersey, March 2, 2020 – Sandoz Inc. has reached a resolution with the U.S. Department of Justice (DOJ) Antitrust Division concerning the Department’s more than three-year-long…